DDX3X and metabolic dysfunction-associated steatotic liver disease: We further analyzed the Gene Expression Omnibus (GEO) database with a larger sample size of 151 NAFLD/NASH patients and 28 controls (GSE213621) and reached the same conclusion that DDX3X expression was decreased in NASH patients (Fig. S1A).